Connection

JIANMING XU to Liver Neoplasms

This is a "connection" page, showing publications JIANMING XU has written about Liver Neoplasms.
Connection Strength

0.042
  1. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism. J Biol Chem. 1995 Mar 17; 270(11):6308-13.
    View in: PubMed
    Score: 0.015
  2. Genomic structure and cloned cDNAs predict that four variants in the kinase domain of serine/threonine kinase receptors arise by alternative splicing and poly(A) addition. Proc Natl Acad Sci U S A. 1994 Aug 16; 91(17):7957-61.
    View in: PubMed
    Score: 0.014
  3. Loss of steroid receptor co-activator-3 attenuates carbon tetrachloride-induced murine hepatic injury and fibrosis. Lab Invest. 2009 Aug; 89(8):903-14.
    View in: PubMed
    Score: 0.010
  4. A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor beta, or bone morphogenic factor. J Biol Chem. 1993 Jun 15; 268(17):12719-23.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.